151 related articles for article (PubMed ID: 27447083)
1. Biomarkers for the prediction of venous thromboembolism in the community.
Puurunen MK; Enserro D; Xanthakis V; Larson MG; Benjamin EJ; Tofler GH; Wollert KC; O'Donnell CJ; Vasan RS
Thromb Res; 2016 Sep; 145():34-9. PubMed ID: 27447083
[TBL] [Abstract][Full Text] [Related]
2. Association between red cell distribution width and risk of venous thromboembolism.
Bucciarelli P; Maino A; Felicetta I; Abbattista M; Passamonti SM; Artoni A; Martinelli I
Thromb Res; 2015 Sep; 136(3):590-4. PubMed ID: 26220270
[TBL] [Abstract][Full Text] [Related]
3. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study.
Hald EM; Lijfering WM; Mathiesen EB; Johnsen SH; Løchen ML; Njølstad I; Wilsgaard T; Rosendaal FR; Brækkan SK; Hansen JB
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):226-30. PubMed ID: 24177328
[TBL] [Abstract][Full Text] [Related]
4. Seasonal variation in the occurrence of venous thromboembolism: a report from the Korean Venous Thromboembolism Working Party.
Jang MJ; Kim HJ; Bang SM; Lee JO; Yhim HY; Kim YK; Kim YK; Choi WI; Lee EY; Kim IH; Park S; Sohn HJ; Kim DK; Kim M; Oh D
Thromb Res; 2012 Oct; 130(4):e199-202. PubMed ID: 22901545
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as prognostic biomarkers for (cancer-associated) venous thromboembolism.
Anijs RJS; Nguyen YN; Cannegieter SC; Versteeg HH; Buijs JT
J Thromb Haemost; 2023 Jan; 21(1):7-17. PubMed ID: 36695398
[TBL] [Abstract][Full Text] [Related]
6. Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).
Isma N; Svensson PJ; Gottsäter A; Lindblad B
Thromb Res; 2009 Dec; 124(6):663-6. PubMed ID: 19497611
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of Cancer-Associated Thromboembolism.
Mahajan A; Wun T
Cancer Treat Res; 2019; 179():69-85. PubMed ID: 31317481
[TBL] [Abstract][Full Text] [Related]
8. Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.
Al Sayegh F; Almahmeed W; Al Humood S; Marashi M; Bahr A; Al Mahdi H; Bakir S; Al Farhan M
Clin Appl Thromb Hemost; 2009; 15(3):289-96. PubMed ID: 18400764
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and risk factors for venous thromboembolism in lung cancer.
Ay C; Ünal UK
Curr Opin Oncol; 2016 Mar; 28(2):145-9. PubMed ID: 26730487
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism: An overview.
Bruni-Fitzgerald KR
J Vasc Nurs; 2015 Sep; 33(3):95-9. PubMed ID: 26298612
[TBL] [Abstract][Full Text] [Related]
11. Predicting the risk of recurrent venous thromboembolism. The Austrian study on recurrent venous thromboembolism (AUREC).
Kyrle PA; Eischer L
Hamostaseologie; 2013 Aug; 33(3):201-9. PubMed ID: 23712242
[TBL] [Abstract][Full Text] [Related]
12. Refining Risk Prediction for Recurrent Venous Thromboembolism: Can We Do Better?
Xu K; Chan NC
Thromb Haemost; 2020 May; 120(5):725-727. PubMed ID: 32369843
[No Abstract] [Full Text] [Related]
13. Venous thromboembolism in adults with sickle cell disease: experience of a single centre in the UK.
van Hamel Parsons V; Gardner K; Patel R; Thein SL
Ann Hematol; 2016 Jan; 95(2):227-32. PubMed ID: 26490882
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of venous thromboembolism within the first year after Staphylococcus aureus bacteraemia: a nationwide observational matched cohort study.
Mejer N; Westh H; Schønheyder HC; Jensen AG; Larsen AR; Skov R; Benfield T;
J Intern Med; 2014 Apr; 275(4):387-97. PubMed ID: 24118528
[TBL] [Abstract][Full Text] [Related]
15. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
[TBL] [Abstract][Full Text] [Related]
16. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.
Vu K; Luong NV; Hubbard J; Zalpour A; Faderl S; Thomas DA; Yang D; Kantarjian H; Kroll MH
Cancer Med; 2015 Jan; 4(1):27-35. PubMed ID: 25487644
[TBL] [Abstract][Full Text] [Related]
18. Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.
Sanfilippo KM; Wang TF; Gage BF; Luo S; Riedell P; Carson KR
Thromb Res; 2016 Jul; 143():86-90. PubMed ID: 27208462
[TBL] [Abstract][Full Text] [Related]
19. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.
Ashrani AA; Barsoum MK; Crusan DJ; Petterson TM; Bailey KR; Heit JA
Thromb Res; 2015 Jun; 135(6):1110-6. PubMed ID: 25891841
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation.
Riva N; Donadini MP; Ageno W
Thromb Haemost; 2015 Jun; 113(6):1176-83. PubMed ID: 25472800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
